Jun 30, 2014

United Therapeutics Q2 2014 Earnings Report

Total Revenue
$323M
Previous year: $281M
+15.0%
EPS
$2.3
Previous year: $3.11
-26.0%
Gross Profit
$284M
Previous year: $248M
+14.4%
Cash and Equivalents
$259M
Previous year: $344M
-24.6%
Total Assets
$1.95B
Previous year: $1.78B
+9.9%

United Therapeutics

United Therapeutics